Imipramine-mediated Suppression of EGFR Signaling Attenuates Invasive and Progressive Abilities of Hepatocellular Carcinoma Cells
Contact us if these videos are not relevant.
Contact us if these videos are not relevant.
View abstract on PubMed
Summary
This summary is machine-generated.Imipramine enhances hepatocellular carcinoma (HCC) treatment by inducing cancer cell death and suppressing metastasis. This drug targets the EGFR/MEK/ERK pathway, showing promise for improving HCC therapy outcomes.
Area Of Science
- Oncology
- Molecular Biology
- Pharmacology
Background
- Hepatocellular carcinoma (HCC) presents a significant global health challenge due to high mortality rates.
- Imipramine, an established pharmaceutical, has shown potential in augmenting conventional cancer therapies.
- Investigating imipramine's role in HCC treatment is crucial for developing novel therapeutic strategies.
Purpose Of The Study
- To explore the potential of imipramine in regulating hepatocellular carcinoma (HCC).
- To assess imipramine's effects on HCC cell viability, apoptosis, and metastasis.
- To elucidate the molecular mechanisms underlying imipramine's action in HCC.
Main Methods
- Utilized MTT assays, flow cytometry, and western blotting to evaluate imipramine's effects.
- Assessed cytotoxicity, apoptosis induction, and metastatic potential in HCC cell lines (Huh7 and Hep3B).
- Investigated the impact of imipramine on key signaling pathways, including the EGFR/MEK/ERK cascade.
Main Results
- Imipramine significantly induced cytotoxicity and apoptosis in HCC cells in a time- and dose-dependent manner.
- Demonstrated imipramine's ability to activate both extrinsic (Fas-Fas-L) and intrinsic (mitochondrial) apoptotic pathways.
- Observed suppression of HCC cell metastasis and inhibition of the EGFR/MEK/ERK signaling pathway.
Conclusions
- Imipramine exhibits considerable promise as an adjunct therapy for hepatocellular carcinoma (HCC).
- The drug effectively targets the EGFR/MEK/ERK signaling pathway in in vitro HCC models.
- Imipramine has the potential to enhance the efficacy of standard cancer treatments for HCC patients.
Contact us if these videos are not relevant.
Contact us if these videos are not relevant.
Related Concept Videos
Mitogens and their receptors play a crucial role in controlling the progression of the cell cycle. However, the loss of mitogenic control over cell division leads to tumor formation. Therefore, mitogens and mitogen receptors play an important role in cancer research. For instance, the epidermal growth factor (EGF) - a type of mitogen and its transmembrane receptor (EGFR), decides the fate of the cell's proliferation. When EGF binds to EGFR, a member of the ErbB family of tyrosine kinase...
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...